These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8088382)

  • 1. Treatment of hypogammaglobulinaemia in chronic lymphocytic leukaemia by low-dose intravenous gammaglobulin.
    Jurlander J; Geisler CH; Hansen MM
    Eur J Haematol; 1994 Aug; 53(2):114-8. PubMed ID: 8088382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlations between secondary hypogammaglobulinaemia, infections and mortality and the need for preventive immunoglobulin replacement in patients with chronic lymphoid leukaemia].
    Losonczy H; Nagy Á; Kosztolányi S; Tóth O; Csalódi R; Hussain A; Szomor Á
    Orv Hetil; 2019 Sep; 160(38):1487-1494. PubMed ID: 31537095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of intravenous immunoglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinaemia.
    Boughton BJ; Jackson N; Lim S; Smith N
    Clin Lab Haematol; 1995 Mar; 17(1):75-80. PubMed ID: 7621634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immune globulin in chronic lymphocytic leukaemia.
    Gamm H; Huber C; Chapel H; Lee M; Ries F; Dicato MA
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):17-20. PubMed ID: 8033428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of various doses of intravenous polyclonal IgG on in vivo levels of 12 pneumococcal antibodies in patients with chronic lymphocytic leukaemia and multiple myeloma.
    Sklenar I; Schiffman G; Jønsson V; Verhoef G; Birgens H; Boogaerts M; Ferrant A; Christensen BE; Hasle H; Drivsholm A
    Oncology; 1993; 50(6):466-77. PubMed ID: 8233289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin replacement therapy in chronic lymphocytic leukaemia patients with hypogammaglobulinaemia and infection.
    Keegan A; Dennington PM; Dhondy N; Mulligan SP
    Eur J Haematol; 2022 Jun; 108(6):460-468. PubMed ID: 35152500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical significance of hypogammaglobulinaemia and serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukaemia (CLL).
    Best OG; Crassini K; Freeman JA; Mulligan SP;
    Scand J Infect Dis; 2013 Sep; 45(9):729. PubMed ID: 23826794
    [No Abstract]   [Full Text] [Related]  

  • 8. Case 22-2005: intravenous immune globulin in chronic lymphocytic leukemia.
    Newcom SR
    N Engl J Med; 2005 Oct; 353(17):1862-3; author reply 1862-3. PubMed ID: 16251548
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia.
    Svensson T; Höglund M; Cherif H
    Scand J Infect Dis; 2013 Jul; 45(7):537-42. PubMed ID: 23427875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial Serum Immunoglobulin G (IgG) Trough Levels in Patients with X-linked Agammaglobulinemia on Replacement Therapy with Intravenous Immunoglobulin: Its Correlation with Infections in Indian Children.
    Suri D; Bhattad S; Sharma A; Gupta A; Rawat A; Sehgal S; Singh S; Gupta S
    J Clin Immunol; 2017 Apr; 37(3):311-318. PubMed ID: 28321612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study.
    Molica S; Musto P; Chiurazzi F; Specchia G; Brugiatelli M; Cicoira L; Levato D; Nobile F; Carotenuto M; Liso V; Rotoli B
    Haematologica; 1996; 81(2):121-6. PubMed ID: 8641639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors.
    Griffiths H; Brennan V; Lea J; Bunch C; Lee M; Chapel H
    Blood; 1989 Feb; 73(2):366-8. PubMed ID: 2492832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous gammaglobulin treatment in patients with hypogammaglobulinaemia.
    So A; Brenner MK; Hill ID; Asherson GL; Webster AD
    Br Med J (Clin Res Ed); 1984 Nov; 289(6453):1177-8. PubMed ID: 6437475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG testing, immunoglobulin replacement therapy, and infection outcomes in patients with CLL or NHL: real-world evidence.
    Soumerai JD; Yousif Z; Gift T; Desai R; Huynh L; Ye M; Banatwala A; Clear L; Pinaire M; Belsky G; Hsieh YG; Herrick C; Darnell EP; Duh MS; Sanchirico M; Murphy SN
    Blood Adv; 2024 Aug; 8(16):4239-4249. PubMed ID: 38904477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin replacement in chronic lymphocytic leukaemia.
    Bunch C
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):419-22. PubMed ID: 3065737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin replacement in patients with chronic lymphocytic leukemia (CLL): kinetics of immunoglobulin metabolism.
    Chapel HM; Lee M
    J Clin Immunol; 1992 Jan; 12(1):17-20. PubMed ID: 1551938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypogammaglobulinaemia in low grade B cell tumours; significance and therapy.
    Chapel H; Griffiths H; Brennan V; Bunch C; Lea J; Lee M
    Immunol Invest; 1991 Apr; 20(2):187-91. PubMed ID: 1864637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High- vs low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia.
    Liese JG; Wintergerst U; Tympner KD; Belohradsky BH
    Am J Dis Child; 1992 Mar; 146(3):335-9. PubMed ID: 1543181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemia.
    Hensel M; Kornacker M; Yammeni S; Egerer G; Ho AD
    Br J Haematol; 2003 Aug; 122(4):600-6. PubMed ID: 12899715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of the safety of three intravenous immunoglobulin preparations in patients with primary hypogammaglobulinaemia.
    Yap PL; McClelland DB
    J Infect; 1986 Jan; 12(1):5-10. PubMed ID: 3082994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.